Experience the Power of 1st Principle
Multispecific Constructs
Molecular Glues, BiDACs, PROTACs, Ubiquitination, ADCs, Bispecific antibodies etc.
Complicated Quantifications
Immunogenicity, Combined Quantity & Affinity, Clone Selection, etc.
Join the Fidabio Mobilization
Fachhochschule, Basel, implemented a Fida 1 instrument amongst others to carry out complex oligomeric analysis and develop comprehensive assays for determining molecular integrity.
The Jørgen Kjems Group at the Interdisciplinary Nanoscience Center at Aarhus University has after intensive testing implemented their first Fida 1 instrument primarily for protein-nucleotide interactions analysis.
Fachhochschule, Basel, got their second Fida 1 instrument.
DTU Bioengineering, Andreas H. Laustsen, has acquired a Fidabio system for high-throughput biophysical characterization of therapeutic antibodies etc.
Agilent has acquired a Fida 1 amongst others to enable them to ensure consistent, high quality of their antibodies through the determination of quantity and affinity with a single FIDA analysis.
Exosome therapeutics leader, Codiak Biosciences, Inc., has acquired a Fida 1 to quantify and characterise exosomes directly in the fermentation media.
Focus
A completely new way to quantify and characterize complex biology
Applications
Essential New insight
Quantitative data on complex protein binding, concentration, size etc.
Products
Unmatched Accuracy
Speed up your decisions with fast development of specific assays.
Technology
A New Paradigm
Intuitive technology with high data reproducibility and built-in quality control.
The FIDA technology represents a revolution in the analysis of proteins and nanoparticles.
Join the new paradigm.
At Fidabio, we are committed to assist you in accelerating your R&D projects. For this we have developed the FIDA technology enabling simple, accurate, and fast detection and characterization of proteins & nanoparticles under native conditions.
